701 results on '"Bihrle, Richard"'
Search Results
2. Ileal Ureter Utilization in Patients With Previous Urinary Diversions
3. Early and Midterm Complications of the Continent Catheterizable Indiana Pouch Urinary Diversion: A 7-year Experience
4. Longitudinal Health Related Quality of Life After Open Radical Cystectomy: Comparison of Ileal Conduit, Indiana Pouch, and Orthotopic Neobladder
5. Improving postoperative quality of care in germ cell tumor patients: Does scheduled alvimopan, acetaminophen, and gabapentin improve short-term clinical outcomes after retroperitoneal lymph node dissection?
6. A Prospective Program to Reduce the Clinical Incidence of Clostridium Difficile Colitis Infection after Cystectomy
7. Prognostic Effect of Carcinoma In Situ in Muscle-invasive Urothelial Carcinoma Patients Receiving Neoadjuvant Chemotherapy
8. Long-term Health-related Quality of Life Outcomes Following Radical Cystectomy
9. Ureteral Reconstruction With Ileum: Long-term Follow-up of Renal Function
10. Primary Choriocarcinoma of the Bladder: A Case Report and Review of Literature
11. Management of Pelvic Metastases in Patients With Testicular Cancer
12. Long term outcomes in the use of ileal ureter for radiation-induced ureteral strictures
13. Supplementary Figure Legend from A Phase II Trial of Dovitinib in BCG-Unresponsive Urothelial Carcinoma with FGFR3 Mutations or Overexpression: Hoosier Cancer Research Network Trial HCRN 12-157
14. Does Squamous Differentiation Portend Worse Outcomes in Urothelial Bladder Cancer?
15. Risk of Recurrence for Clinical Stage I and II Patients With Teratoma Only at Primary Retroperitoneal Lymph Node Dissection
16. Short-term morbidity and mortality of Indiana pouch, ileal conduit, and neobladder urinary diversion following radical cystectomy
17. Survival Analysis of Pure Seminoma at Post-Chemotherapy Retroperitoneal Lymph Node Dissection
18. Critical analysis of the 2010 TNM classification in patients with lymph node–positive bladder cancer: Influence of lymph node disease burden
19. Plasmacytoid variant urothelial bladder cancer: Is it time to update the treatment paradigm?
20. Reoperative Retroperitoneal Lymph Node Dissection for Metastatic Germ Cell Tumors: Analysis of Local Recurrence and Predictors of Survival
21. Plasmacytoid Bladder Cancer: Variant Histology With Aggressive Behavior and a New Mode of Invasion Along Fascial Planes
22. Incidence and Risk Factors of Parastomal Hernia in Patients Undergoing Radical Cystectomy and Ileal Conduit Diversion
23. Incidence, Histology and Management of Intraluminal Thrombus at Post-Chemotherapy Retroperitoneal Lymph Node Dissection
24. Clinical and Pathological Features Predictive of Nephrectomy at Post-Chemotherapy Retroperitoneal Lymph Node Dissection
25. Serum tumor markers in testicular cancer
26. ADJUSTED CLINICAL OUTCOMES IN PATIENTS WITH SARCOMATOID VARIANT UROTHELIAL CARCINOMA UNDERGOING RADICAL CYSTECTOMY FOR MUSCLE INVASIVE DISEASE: PD33-03
27. EMPIRIC TREATMENT OF IDENTIFIED CLOSTRIDIUM DIFFICILE CARRIERS AT TIME OF CYSTECTOMY: PRELIMINARY OUTCOMES: MP56-02
28. A STUDY TO EVALUATE THE PROGNOSTIC AND PREDICTIVE UTILITY OF CCP AND HRD ASSAYS AND GENETIC SEQUENCING IN PATIENTS UNDERGOING NEOADJUVANT CHEMOTHERAPY IN BLADDER CANCER: MP49-02
29. LONG-TERM 10-YEAR HEALTH-RELATED QUALITY OF LIFE OUTCOMES FOLLOWING RADICAL CYSTECTOMY: MP38-13
30. Evolving concepts in surgical management of testis cancer
31. Ejaculatory Status and Fertility Rates After Primary Retroperitoneal Lymph Node Dissection
32. Is Retroperitoneal Histology Predictive of Liver Histology at Concurrent Post-Chemotherapy Retroperitoneal Lymph Node Dissection and Hepatic Resection?
33. The changing reality of urothelial bladder cancer: should non-squamous variant histology be managed as a distinct clinical entity?
34. MP65-14 INCIDENCE AND RISK FOR CLOSTRIDIUM DIFFICILE INFECTIOUS COLITIS IN PATIENTS UNDERGOING RADICAL CYSTECTOMY FOR BLADDER CANCER
35. MP64-17 LACK OF IMPROVEMENT IN RADICAL CYSTECTOMY OUTCOMES OVER 20 YEARS?
36. MP58-11 DOES SQUAMOUS DIFFERENTIATION PORTEND WORSE OUTCOMES IN UROTHELIAL BLADDER CANCER?
37. MP29-11 URETERAL RECONSTRUCTION WITH ILEUM: LONG TERM FOLLOW-UP OF RENAL FUNCTION
38. MP29-12 USE OF THE ILEAL URETER FOR RADIATION-INDUCED URETERAL STRICTURES
39. MP10-17 MANAGEMENT OF CHYLOUS LEAK AFTER RETROPERITONEAL LYMPH NODE DISSECTION FOR ADVANCED TESTICULAR CANCER
40. MP10-08 MODIFIED TEMPLATE RETROPERITONEAL LYMPH NODE DISSECTION FOR POSTCHEMOTHERAPY RESIDUAL TUMOR: A LONG TERM UPDATE
41. Long-Term Outcome for Patients With High Volume Retroperitoneal Teratoma Undergoing Post-Chemotherapy Surgery
42. Use of Ileum as Ureteral Replacement in Urological Reconstruction
43. Neoadjuvant dasatinib for muscle-invasive bladder cancer with tissue analysis of biologic activity
44. Delayed Orchiectomy at Postchemotherapy Retroperitoneal Lymph Node Dissection Due to Laterality of Retroperitoneal Metastatic Pattern Consistent with Testicular Primary: Assessment of Pathologic Findings
45. CAN LYMPHOVASCULAR INVASION BE USED AS A SURROGATE FOR LYMPH NODE INVOLVEMENT IN PATIENTS WITH UPPER TRACT UROTHELIAL CARCINOMA?: MP77-18
46. PROPOSED NODAL STAGING CLASSIFICATION IN UROTHELIAL CARCINOMA OF THE BLADDER BASED ON BURDEN OF LYMPH LODE INVOLVEMENT: MP65-17
47. EFFICACY OF NEOADJUVANT CHEMOTHERAPY IN BLADDER CANCER: MP55-19
48. SIGNIFICANCE OF LYMPH NODE INVOLVEMENT IN VARIANT HISTOLOGY UROTHELIAL BLADDER CANCER: MP55-07
49. SURGICAL MANAGEMENT OF RETROCRURAL DISEASE IN TESTIS CANCER: OUTCOMES AND EVOLUTION OF PRACTICE: PD5-05
50. Ventral onlay buccal mucosa urethroplasty: A 10-year experience
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.